Synergistic induction of osteopontin by aldosterone and inflammatory cytokines in mesangial cells

Journal of Cellular Biochemistry

Volumn 103, Issue 2, 2008, Pages 615-623

  Gauer, Stefan ^a   Hauser, Ingeborg A ^a   Obermüller, Nicholas ^a   Holzmann, Yvonne ^a   Geiger, Helmut ^a   Goppelt Struebe, Margarete ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aldosterone; Mesangial cells; Osteopontin

Indexed keywords

ALDOSTERONE; CYTOKINE; DIPHENYLIODONIUM SALT; INTERLEUKIN 1BETA; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE INDUCTION; HYPERTENSION; IMMUNOPRECIPITATION; INFLAMMATION; INHIBITION KINETICS; LYMPHOCYTIC INFILTRATION; MESANGIUM CELL; MOLECULAR INTERACTION; MONONUCLEAR CELL; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALDOSTERONE; ANIMALS; CHEMOTAXIS, LEUKOCYTE; DRUG SYNERGISM; HYPERTENSION; INTERLEUKIN-1BETA; MESANGIAL CELLS; NEPHROSCLEROSIS; ONIUM COMPOUNDS; OSTEOPONTIN; PROMOTER REGIONS (GENETICS); RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38649098809     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21433     Document Type: Article

References (38)

1. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. 2000. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287:860-864.
2. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. 2003. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63:1791-1800.
3. Chang PL, Tucker MA, Hicks PH, Prince CW. 2002. Novel protein kinase C isoforms and mitogen-activated kinase mediate phorbol ester-induced osteopontin expression. Int J Biochem Cell Biol 34:1142-1151.
4. Cohn JN, Anand IS, Latini R, Masson S, Chiang YT, Glazer R. 2003. Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial. Circulation 108:1306-1309.
5. Fiebeler A, Luft FC. 2005. The mineralocorticoid receptor and oxidative stress. Heart Fail Rev 10:47-52.
6. Friedrich B, Warntges S, Klingel K, Sauter M, Kandolf R, Risler T, Muller GA, Witzgall R, Kriz W, Grone HJ, Lang F. 2002. Upregulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res 25:303-307.
7. Fuller PJ, Young MJ. 2005. Mechanisms of mineralocorticoid action. Hypertension 46:1227-1235.
8. Gauer S, Hartner A, Hauser IA, Fierlbeck W, Eberhardt W, Geiger H. 2003. Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats. Am J Hypertens 16:214-222.
9. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358.
10. Goppelt-Struebe M, Wiedemann T, Heusinger-Ribeiro J, Vucadinovic M, Rehm M, Prols F. 2000. Cox-2 and osteopontin in cocultured platelets and mesangial cells: Role of glucocorticoids. Kidney Int 57:2229-2238.
11. Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR. 2006. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol 17:1362-1372.
12. Hartner A, Porst M, Gauer S, Prols F, Veelken R, Hilgers KF. 2001. Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. Am J Kidney Dis 38:153-164.
13. Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, Ganten D, Geiger H, Veelken R, Mann JF. 2000. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 58:2408-2419.
14. Hostetter TH, Rosenberg ME, Ibrahim HN, Juknevicius I. 2001. Aldosterone in progressive renal disease. Semin Nephrol 21:573-579.
15. Kellner M, Peiter A, Hafner M, Feuring M, Christ M, Wehling M, Falkenstein E, Losel R. 2003. Early aldosterone upregulated genes: New pathways for renal disease? Kidney Int 64:1199-1207.
16. Lai L, Chen J, Hao CM, Lin S, Gu Y. 2006. Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochem Biophys Res Commun 348:70-75.
17. Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombes M. 2001. Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 276:38911-38920.
18. Lovett DH, Ryan JL, Sterzel RB. 1983. A thymocyte-activating factor derived from glomerular mesangial cells. J Immunol 130:1796-1801.
19. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J, Luft FC. 1993. Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754-765.
20. Mai M, Hilgers KF, Geiger H. 1996. Experimental studies on the role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in hypertensive nephrosclerosis. Hypertension 28:973-979.
21. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. 2002. Osteopontin - A molecule for all seasons. QJM 95:3-13.
22. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, Yukimura T, Kiyomoto H, Kohno M, Abe Y, Nishiyama A. 2005. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 16:2906-2912.
23. Modena MG, Aveta P, Menozzi A, Rossi R. 2001. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J 141:41-46.
24. Nian M, Lee P, Khaper N, Liu P. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543-1553.
25. Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F, Abe Y. 2005. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 45:710-716.
26. Norris K, Vaughn C. 2003. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther 1:51-63.
27. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ. 1999. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580.
28. Remuzzi G, Perico N, Macia M, Ruggenenti P. 2005. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 99:S57-S65.
29. Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP. 2005. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 280:2708-2713.
30. Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR. 2000. Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Physiol 278:F708-F716.
31. Schaefers HJ, Goppelt-Struebe M. 1996. Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells. Biochem Pharmacol 52:1415-1421.
32. Sen S, Tarazi RC, Bumpus FM. 1977. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 11:427-433.
33. Struthers AD. 2002. Impact of aldosterone on vascular pathophysiology. Congest Heart Fail 8:18-22.
34. Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S. 2005. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2,cyclin D1, and cyclin A. J Am Soc Nephrol 16:2296-2305.
35. Todd-Turla KM, Schnermann J, Fejes-Toth G, Naray-Fejes-Toth A, Smart A, Killen PD, Briggs JP. 1993. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol 264:F781-F791.
36. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. 2002. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 72:752-761.
37. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG, Hopfer U. 1996. Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int 50:125-134.
38. Xie Z, Singh M, Singh K. 2004. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol 198:399-407.